Immuron

Manufacturing news briefs – stories you might have missed

Manufacturing sector roundup: Whyalla steelworks resumes production, Maggie Beer Holdings' chief executive to depart, ReNu Energy secures hydrogen funding, Defence names grant recipients, Orthocell gains Canadian approval, and AEA appoints its advisory board.

Manufacturing news briefs – stories you might have missed

Roundup covering Hanwha defence testing, a PPK Group CEO promotion, Immuron's sales growth, an Australian Vanadium retirement, Lumos Diagnostics' $4.75 million placement, and TAFE Queensland scholarships.

Manufacturing news briefs – stories you might have missed

Manufacturing roundup: Imagion Biosystems raises six million dollars, Immuron receives an R&D tax payment, UNSW Canberra Space completes cubesat testing, and Australian Vanadium signs a green hydrogen supply deal.

Immuron reveals anti-Covid potential, raises $28 million

Biotech Immuron raised $28 million from US institutional investors after reporting its Travelan product showed antiviral activity against coronavirus in a laboratory study, and holds a US defence grant.

Immuron receives US funding to develop gut treatment

ASX-listed gut health company Immuron has been awarded a $5.5 million grant by the US Department of Defence to develop an anti-microbial oral drug targeting diarrhoea-causing bacteria for military and traveller use.

Also @AuManufacturing